Dr. Kaldas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17 Davis Blvd Ste 308
Tampa, FL 33606
Summary
- Resident Physician
Education & Training
Cairo University School of MedicineClass of 2016
Publications & Presentations
PubMed
- Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, Frances Shepherd, Elio Adib
Journal of Thoracic Oncology. 2024-09-10 - 1 citationsPatterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia.Akriti G Jain, Somedeb Ball, Luis Aguirre, Najla Al Ali, David Kaldas
Haematologica. 2024-07-01 - 1 citationsClinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.Amin H Nassar, Talal El Zarif, Ahmed Bilal Khalid, Serena Rahme, Caiwei Zhong
Journal for Immunotherapy of Cancer. 2024-03-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
